レボノルゲストレルAPIのグローバル及び中国市場インサイト・予測(~2027年)

QYResearchが発行した調査報告書(QY21CN4200)
◆英語タイトル:Global and China Levonorgestrel API Market Insights, Forecast to 2027
◆商品コード:QY21CN4200
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年7月1日(※2024年版があります。お問い合わせください。)
◆ページ数:135
◆レポート形式:英語 / PDF
◆納品方法:Eメール(24時間以内)
◆調査対象地域:グローバル、中国
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートではグローバルにおけるレボノルゲストレルAPIの市場規模(2016年-2027年)と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、レボノルゲストレルAPIの種類別市場規模(短時間作用型避妊API、長時間作用型避妊API)、用途別市場規模(レボノルゲストレル錠、混合物、ホルモン放出IUD)も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。
・調査の概要
・調査のサマリー
・世界のレボノルゲストレルAPI市場動向
・グローバル主要プレイヤーの競争状況・市場シェア
・世界におけるレボノルゲストレルAPIの種類別市場規模(2016年-2027年):短時間作用型避妊API、長時間作用型避妊API
・世界におけるレボノルゲストレルAPIの用途別市場規模(2016年-2027年):レボノルゲストレル錠、混合物、ホルモン放出IUD
・レボノルゲストレルAPIの中国市場分析
- レボノルゲストレルAPIの中国市場規模(2016年-2027年)
- 中国におけるレボノルゲストレルAPIの主要プレイヤー別市場シェア
- 中国におけるレボノルゲストレルAPIの種類別市場規模:短時間作用型避妊API、長時間作用型避妊API
- 中国におけるレボノルゲストレルAPIの用途別市場規模:レボノルゲストレル錠、混合物、ホルモン放出IUD
・レボノルゲストレルAPIの北米市場(2016年-2027年)
・レボノルゲストレルAPIのヨーロッパ市場(2016年-2027年)
・レボノルゲストレルAPIのアジア太平洋市場(2016年-2027年)
・レボノルゲストレルAPIの中南米市場(2016年-2027年)
・レボノルゲストレルAPIの中東・アフリカ市場(2016年-2027年)
・主要プレイヤーの情報:Bayer HealthCare、Qinhuangdao Zizhu Pharmaceutical、Yangzhou Pharmaceutical、Lupin、Hubei Gedian Humanwell、Sterling Spa、Formos、Huazhong Pharm、ASG Biochem
・市場機会・課題・リスク要因分析
・バリューチェーン・販売チャネル分析
・...
【レポートの概要】

Levonorgestrel is a hormonal medication which is used in a number of birth control methods.
By type, the Global Levonorgestrel API market share is the highest in the short-acting contraceptive API, about 67.17%. The most proportion of the Global Levonorgestrel API market share is used for Levonorgestrel Tablet and the proportion is about 52.74% in 2020.

Market Analysis and Insights: Global and China Levonorgestrel API Market
This report focuses on global and China Levonorgestrel API market.
In 2020, the global Levonorgestrel API market size was US$ 46 million and it is expected to reach US$ 60 million by the end of 2027, with a CAGR of 4.0% during 2021-2027. In China the Levonorgestrel API market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Levonorgestrel API Scope and Market Size
Levonorgestrel API market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Levonorgestrel API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Levonorgestrel API market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Short-Acting Contraceptive API
Long-Acting Contraceptive API

Segment by Application
Levonorgestrel Tablet
Mixture Products
Hormone-releasing IUD

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Bayer HealthCare
Qinhuangdao Zizhu Pharmaceutical
Yangzhou Pharmaceutical
Lupin
Hubei Gedian Humanwell
Sterling Spa
Formos
Huazhong Pharm
ASG Biochem

【レポートの目次】

1 Study Coverage
1.1 Levonorgestrel API Product Introduction
1.2 Market by Type
1.2.1 Global Levonorgestrel API Market Size Growth Rate by Type
1.2.2 Short-Acting Contraceptive API
1.2.3 Long-Acting Contraceptive API
1.3 Market by Application
1.3.1 Global Levonorgestrel API Market Size Growth Rate by Application
1.3.2 Levonorgestrel Tablet
1.3.3 Mixture Products
1.3.4 Hormone-releasing IUD
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Levonorgestrel API Market Size, Estimates and Forecasts
2.1.1 Global Levonorgestrel API Revenue 2016-2027
2.1.2 Global Levonorgestrel API Sales 2016-2027
2.2 Global Levonorgestrel API, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Levonorgestrel API Historical Market Size by Region (2016-2021)
2.3.1 Global Levonorgestrel API Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Levonorgestrel API Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Levonorgestrel API Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Levonorgestrel API Sales Forecast by Region (2022-2027)
2.4.2 Global Levonorgestrel API Revenue Forecast by Region (2022-2027)

3 Global Levonorgestrel API Competitor Landscape by Players
3.1 Global Top Levonorgestrel API Manufacturers by Sales
3.1.1 Global Levonorgestrel API Sales by Manufacturer (2016-2021)
3.1.2 Global Levonorgestrel API Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Levonorgestrel API Manufacturers by Revenue
3.2.1 Key Levonorgestrel API Manufacturers Covered: Ranking by Revenue
3.2.2 Global Levonorgestrel API Revenue by Manufacturers (2016-2021)
3.2.3 Global Levonorgestrel API Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Levonorgestrel API Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Levonorgestrel API Revenue in 2020
3.2.6 Global Levonorgestrel API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Levonorgestrel API Price by Manufacturers
3.4 Global Levonorgestrel API Manufacturing Base Distribution, Product Types
3.4.1 Levonorgestrel API Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Levonorgestrel API Product Type
3.4.3 Date of International Manufacturers Enter into Levonorgestrel API Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Levonorgestrel API Market Size by Type (2016-2021)
4.1.1 Global Levonorgestrel API Sales by Type (2016-2021)
4.1.2 Global Levonorgestrel API Revenue by Type (2016-2021)
4.1.3 Levonorgestrel API Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Levonorgestrel API Market Size Forecast by Type (2022-2027)
4.2.1 Global Levonorgestrel API Sales Forecast by Type (2022-2027)
4.2.2 Global Levonorgestrel API Revenue Forecast by Type (2022-2027)
4.2.3 Levonorgestrel API Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Levonorgestrel API Market Size by Application (2016-2021)
5.1.1 Global Levonorgestrel API Sales by Application (2016-2021)
5.1.2 Global Levonorgestrel API Revenue by Application (2016-2021)
5.1.3 Levonorgestrel API Price by Application (2016-2021)
5.2 Levonorgestrel API Market Size Forecast by Application (2022-2027)
5.2.1 Global Levonorgestrel API Sales Forecast by Application (2022-2027)
5.2.2 Global Levonorgestrel API Revenue Forecast by Application (2022-2027)
5.2.3 Global Levonorgestrel API Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Levonorgestrel API Market Size YoY Growth 2016-2027
6.1.1 China Levonorgestrel API Sales YoY Growth 2016-2027
6.1.2 China Levonorgestrel API Revenue YoY Growth 2016-2027
6.1.3 China Levonorgestrel API Market Share in Global Market 2016-2027
6.2 China Levonorgestrel API Market Size by Players (International and Local Players)
6.2.1 China Top Levonorgestrel API Players by Sales (2016-2021)
6.2.2 China Top Levonorgestrel API Players by Revenue (2016-2021)
6.3 China Levonorgestrel API Historic Market Review by Type (2016-2021)
6.3.1 China Levonorgestrel API Sales Market Share by Type (2016-2021)
6.3.2 China Levonorgestrel API Revenue Market Share by Type (2016-2021)
6.3.3 China Levonorgestrel API Price by Type (2016-2021)
6.4 China Levonorgestrel API Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Levonorgestrel API Sales Forecast by Type (2022-2027)
6.4.2 China Levonorgestrel API Revenue Forecast by Type (2022-2027)
6.4.3 China Levonorgestrel API Price Forecast by Type (2022-2027)
6.5 China Levonorgestrel API Historic Market Review by Application (2016-2021)
6.5.1 China Levonorgestrel API Sales Market Share by Application (2016-2021)
6.5.2 China Levonorgestrel API Revenue Market Share by Application (2016-2021)
6.5.3 China Levonorgestrel API Price by Application (2016-2021)
6.6 China Levonorgestrel API Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Levonorgestrel API Sales Forecast by Application (2022-2027)
6.6.2 China Levonorgestrel API Revenue Forecast by Application (2022-2027)
6.6.3 China Levonorgestrel API Price Forecast by Application (2022-2027)

7 North America
7.1 North America Levonorgestrel API Market Size YoY Growth 2016-2027
7.2 North America Levonorgestrel API Market Facts & Figures by Country
7.2.1 North America Levonorgestrel API Sales by Country (2016-2021)
7.2.2 North America Levonorgestrel API Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Levonorgestrel API Market Size YoY Growth 2016-2027
8.2 Asia Pacific Levonorgestrel API Market Facts & Figures by Region
8.2.1 Asia Pacific Levonorgestrel API Sales by Region (2016-2021)
8.2.2 Asia Pacific Levonorgestrel API Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia

9 Europe
9.1 Europe Levonorgestrel API Market Size YoY Growth 2016-2027
9.2 Europe Levonorgestrel API Market Facts & Figures by Country
9.2.1 Europe Levonorgestrel API Sales by Country (2016-2021)
9.2.2 Europe Levonorgestrel API Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Levonorgestrel API Market Size YoY Growth 2016-2027
10.2 Latin America Levonorgestrel API Market Facts & Figures by Country
10.2.1 Latin America Levonorgestrel API Sales by Country (2016-2021)
10.2.2 Latin America Levonorgestrel API Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Levonorgestrel API Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Levonorgestrel API Market Facts & Figures by Country
11.2.1 Middle East and Africa Levonorgestrel API Sales by Country (2016-2021)
11.2.2 Middle East and Africa Levonorgestrel API Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Bayer HealthCare
12.1.1 Bayer HealthCare Corporation Information
12.1.2 Bayer HealthCare Description and Business Overview
12.1.3 Bayer HealthCare Levonorgestrel API Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bayer HealthCare Levonorgestrel API Products Offered
12.1.5 Bayer HealthCare Recent Development
12.2 Qinhuangdao Zizhu Pharmaceutical
12.2.1 Qinhuangdao Zizhu Pharmaceutical Corporation Information
12.2.2 Qinhuangdao Zizhu Pharmaceutical Description and Business Overview
12.2.3 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Products Offered
12.2.5 Qinhuangdao Zizhu Pharmaceutical Recent Development
12.3 Yangzhou Pharmaceutical
12.3.1 Yangzhou Pharmaceutical Corporation Information
12.3.2 Yangzhou Pharmaceutical Description and Business Overview
12.3.3 Yangzhou Pharmaceutical Levonorgestrel API Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Yangzhou Pharmaceutical Levonorgestrel API Products Offered
12.3.5 Yangzhou Pharmaceutical Recent Development
12.4 Lupin
12.4.1 Lupin Corporation Information
12.4.2 Lupin Description and Business Overview
12.4.3 Lupin Levonorgestrel API Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Lupin Levonorgestrel API Products Offered
12.4.5 Lupin Recent Development
12.5 Hubei Gedian Humanwell
12.5.1 Hubei Gedian Humanwell Corporation Information
12.5.2 Hubei Gedian Humanwell Description and Business Overview
12.5.3 Hubei Gedian Humanwell Levonorgestrel API Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Hubei Gedian Humanwell Levonorgestrel API Products Offered
12.5.5 Hubei Gedian Humanwell Recent Development
12.6 Sterling Spa
12.6.1 Sterling Spa Corporation Information
12.6.2 Sterling Spa Description and Business Overview
12.6.3 Sterling Spa Levonorgestrel API Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sterling Spa Levonorgestrel API Products Offered
12.6.5 Sterling Spa Recent Development
12.7 Formos
12.7.1 Formos Corporation Information
12.7.2 Formos Description and Business Overview
12.7.3 Formos Levonorgestrel API Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Formos Levonorgestrel API Products Offered
12.7.5 Formos Recent Development
12.8 Huazhong Pharm
12.8.1 Huazhong Pharm Corporation Information
12.8.2 Huazhong Pharm Description and Business Overview
12.8.3 Huazhong Pharm Levonorgestrel API Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Huazhong Pharm Levonorgestrel API Products Offered
12.8.5 Huazhong Pharm Recent Development
12.9 ASG Biochem
12.9.1 ASG Biochem Corporation Information
12.9.2 ASG Biochem Description and Business Overview
12.9.3 ASG Biochem Levonorgestrel API Sales, Revenue and Gross Margin (2016-2021)
12.9.4 ASG Biochem Levonorgestrel API Products Offered
12.9.5 ASG Biochem Recent Development
12.11 Bayer HealthCare
12.11.1 Bayer HealthCare Corporation Information
12.11.2 Bayer HealthCare Description and Business Overview
12.11.3 Bayer HealthCare Levonorgestrel API Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Bayer HealthCare Levonorgestrel API Products Offered
12.11.5 Bayer HealthCare Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Levonorgestrel API Industry Trends
13.2 Levonorgestrel API Market Drivers
13.3 Levonorgestrel API Market Challenges
13.4 Levonorgestrel API Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Levonorgestrel API Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Bayer HealthCare、Qinhuangdao Zizhu Pharmaceutical、Yangzhou Pharmaceutical、Lupin、Hubei Gedian Humanwell、Sterling Spa、Formos、Huazhong Pharm、ASG Biochem

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ レボノルゲストレルAPIのグローバル及び中国市場インサイト・予測(~2027年)(Global and China Levonorgestrel API Market Insights, Forecast to 2027)]についてメールでお問い合わせはこちらでお願いします。